We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Pre-Clinical Safety in Cancer Drug Development: “Attitude to Safety Needs to Change”

News   Feb 19, 2018 | Original story from ApconiX

 
Pre-Clinical Safety in Cancer Drug Development: “Attitude to Safety Needs to Change”
 
 
 

RELATED ARTICLES

Gene Promotes Resistance to Prostate Cancer Treatments

News

Researchers have discovered how a gene involved in regulating hormone receptors may contribute to drug resistance in some prostate cancer patients.

READ MORE

Concern Over Fake ISO 9001 Accreditation of Chinese Companies

News

A study concludes that fake ISO 9001 quality certificates are very widespread across Chinese companies and that the certification processes of the auditing companies lack credibility.

READ MORE

$11M Study to Jumpstart Radiation Exposure Drug Development

News

The U.S. Department of Defense has turned to the University of Nebraska to jumpstart the development of drug therapies to protect military service members from the effects of radiation exposure.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE